1-Methyl-4-((3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)sulfonyl)piperazine, 95%, 100mg

(S)-3-((2R,5S)-5-(4-Fluorophenyl)-2-((S)-((4-fluorophenyl)amino)(4-((trimethylsilyl)oxy)phenyl)methyl)-5-((trimethylsilyl)oxy)pentanoyl)-4-phenyloxazolidin-2-one, 97%, 1g

(R)-1-(3,4-Difluorophenyl)ethanamine, 95.0%, 5g

1,2-Dimethyl-1H-imidazole-5-carboxylic acid, 95.0%, 250mg

(R)-(+)-2-Amino-3-methyl-1,1-diphenyl-1-butanol>98.0%(HPLC)(T)1g

3,3-Difluoro-2,2-dimethylbutanoic acid, 97%, 50mg

5-iodo-3-(trifluoromethyl)-1H-pyrazole, 98%, 5g

Dimethyl Dipropargylmalonate>98.0%(GC)1g

1-tert-butyl 2-methyl (2S,3R)-3-amino-1,2-pyrrolidinedicarboxylate hydrochloride, 95.0%, 1g

Triadimefon>98.0%(HPLC)5g

N-Cbz-N'-trityl-L-asparagine, 98.0%, 1g

2-(1-Methyl-1H-imidazol-5-yl)ethanamine dihydrochloride, 95.0%, 250mg

(4R,5S)-2-(6-Methylpyridin-2-yl)-4,5-diphenyl-4,5-dihydrooxazole, 97%, 250mg